aXichem AB Stock

AXIC A

SE0005250719

Specialty Chemicals

Market Closed - Nasdaq Stockholm 12:00:00 2026-09-09 pm EDT			5-day change	1st Jan Change
1.805 ^SEK	-4.75%		-14.86%	-12.80%

Aug. 27	AXichem AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
Aug. 26	Calendar Thursday, August 27	FW

aXichem AB (publ) is a Sweden-based biochemical company. It develops an eco-friendly solution, Phenylcapsaicin. Phenylcapsaicin is an non-toxic antifouling agent, which can be used in the shipping industry, as it keeps vessels free from fouling. Additionally, the Company holds several world patents for alternative uses and applications of phenylcapsaicin. Phenylcapsaicin can be applied as bio-repellent against all living organisms in settings where animals cause damage to human installations. As of December 31, 2011, the Company had such subsidiaries, as aXichem AB, aXimed AS, aXimed KH Limited and Guizhou aXimed Health Food Co Ltd. As of June 29, 2012, the Compantâ€™s two largest shareholders were Aximed AB (52.47%) and LMK Ventures AB (12.54%).

Employees

Sector

Specialty Chemicals

Calendar

Nov. 25 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
26-09-09	SEK 1.805	-4.75%	62,912
26-09-08	SEK 1.895	+3.55%	164,618
26-09-07	SEK 1.830	-12.86%	60,753
26-09-04	SEK 2.100	+5.00%	28,792
26-09-03	SEK 2.000	-8.26%	43,429

Delayed Quote Nasdaq Stockholm

More quotes

Market Cap	122M 12.76M 10.96M 10.32M 9.41M 17.61M 1.21B 17.68M 47.24M 619M 47.88M 46.85M 1.97B	P/E 2024	-2.93x	P/E 2025	-6.9x
Enterprise Value	124M 12.93M 11.11M 10.46M 9.54M 17.84M 1.23B 17.92M 47.87M 628M 48.53M 47.48M 2B	EV / Sales 2024	7.67x	EV / Sales 2025	6.72x
Free-Float	82.56%	Yield 2024 *	-	Yield 2025	-

Aug. 27	AXichem AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
Aug. 26	Calendar Thursday, August 27	FW
Jul. 24	AXichem's Salmonella-inhibiting Chicken Feed Additive Gets EU Agency Backing	MT
Jun. 26	AXichem Receives Order for Feed Additives for SEK4.2 Million	MT
Jun. 17	Axichem AB Elects Michael Engstrom As Chairman Of The Board	RE
Jun. 12	Calendar Monday June 15 - Friday June 19	FW
May. 22	Calendar Friday May 22	FW
May. 21	Axichem Q1 operating loss narrows to SEK 2.8 mln	RE
May. 21	AXichem AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
May. 15	Axichem proposes chairman	RE
May. 07	Axichem launches axiphen ruminant in Brazil	RE
Apr. 09	AXichem: Final study report shows aXiphen improves milk production	RE
Mar. 18	Sweden's aXichem Secures Product Registration for Phenylcapsaicin Cattle Feed Additive in Brazil	MT

Sep. 08	AXichem : notes growing commercial adoption in Brazil for aXiphen ruminant as Garra Nutrição increases volume to four tonnes	PU
Aug. 24	AXichem : CEO Torsten Helsing Presents the Report for the Second Quarter 2026 in a Live Web Conference	PU
Aug. 24	AXichem : CEO Torsten Helsing Presents the Report for the Second Quarter 2026 in a Live Web Conference	PU
Jul. 24	AXichem : receives positive scientific opinion from EFSA for phenylcapsaicin as a salmonella-inhibiting additive in chicken feed	PU
Jun. 26	AXichem : receives order for aXiphen from Chr. Olesen in Brazil to a value of SEK 4.2 million, for use in feed for chickens and ruminants	PU

1 day	-4.75%
1 week	-14.86%
Current month	-10.64%
1 month	-39.23%
3 months	+36.74%
6 months	+41.57%
Current year	-12.80%

1 week	1.77	2.2
1 month	1.77	3.2
Current year	1.14	4
1 year	1.14	4
3 years	0.9	15.5
5 years	0.9	30.8
10 years	0.9	95.8

aXichem AB Stock

Stocks

AXIC A

SE0005250719

Specialty Chemicals

Valuation : aXichem AB

Chart: aXichem AB

Latest news : aXichem AB

Press Releases : aXichem AB

Quotes and Performance

Price Extremes

Managers and Directors : aXichem AB

Latest insider transactions

Industrial Biotechnology Chemicals

Financials

Company Profile

Quotes

Manager	Title	Age	Since
Nils Torsten Helsing CEO	Chief Executive Officer	69	2015-12-31
Erik Lager COO	Chief Operating Officer	51	2025-04-15
Gunilla Savring IRC	Investor Relations Contact	64	2014-12-31

Director	Title	Age	Since
Nils Torsten Helsing CHM	Chairman	69	2007-07-05
Jan-Ove Henry Gustavsson CHM	Chairman	80	2016-12-31
Jorn Havskov Berthelsen BRD	Director/Board Member	77	2016-12-31

Date	Insider	Type	Main position	Quantity	% Market Cap.
3/28/24	Christian Mansson	Exercice	Director	33,602	0.1563%
3/28/24	Christian Mansson	Exercice	Director	134,408	0.6253%
3/27/24	Nils Torsten Helsing	Buy	Founder	200,000	0.9304%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AXICHEM AB	-4.75%	-14.86%	-54.53%	-73.92%	13.39M
NOVONESIS A/S	-0.69%	-4.29%	+6.86%	+39.83%	31.6B
CATHAY BIOTECH INC.	-1.09%	-4.68%	-27.99%	-29.91%	4.35B
BORREGAARD ASA	-1.05%	-2.82%	-27.21%	-1.82%	1.65B
PUYANG HUICHENG ELECTRONIC MATERIAL CO., LTD.	-0.14%	-3.61%	-6.72%	-23.82%	604M
HENAN JINDAN LACTIC ACID TECHNOLOGY CO.,LTD.	+0.17%	+7.87%	-13.03%	-18.07%	575M
I-TECH AB	-0.95%	-1.22%	-24.27%	+93.87%	91.89M
SK MINERALS & ADDITIVES LIMITED	+1.40%	+4.75%	-	-	62.95M
Average	-0.89%	-1.72%	-20.99%	-1.98%	4.87B
Weighted average by Cap.	-0.73%	-3.56%	+0.92%	+28.50%

	2024	2025
Net sales	8.57M 895K 768K 724K 660K 1.23M 85.08M 1.24M 3.31M 43.42M 3.36M 3.28M 138M	18.45M 1.93M 1.65M 1.56M 1.42M 2.66M 183M 2.67M 7.13M 93.46M 7.22M 7.07M 298M
Net income	-17.81M -1.86M -1.6M -1.5M -1.37M -2.57M -177M -2.58M -6.88M -90.25M -6.98M -6.83M -287M	-17.63M -1.84M -1.58M -1.49M -1.36M -2.54M -175M -2.55M -6.81M -89.34M -6.91M -6.76M -285M
Net Debt	-14.36M -1.5M -1.29M -1.21M -1.11M -2.07M -143M -2.08M -5.55M -72.75M -5.62M -5.5M -232M	1.64M 172K 147K 139K 127K 237K 16.32M 238K 635K 8.33M 644K 630K 26.53M

Markets		Quality
Nasdaq Stockholm	AXIC A	Delayed
Deutsche Boerse AG	A6X	Delayed